Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Intravenous immunoglobulin for pulmonary diseases. Lansdale: HAYES, Inc.. Directory Publication. 2012 Authors' conclusions The goal of intravenous immunoglobulin (IVIG) for pulmonary diseases is to prevent or reduce the incidence of pulmonary infections or disorders, eliminate or reduce the symptoms or untoward sequelae of pulmonary infections or disorders, and/or improve pulmonary function by enhancing immune capability with components that substitute for immune deficiencies, improve the modulation of inflammatory processes, or allow the destruction of autoantibodies. Indexing Status Subject indexing assigned by CRD MeSH Immunoglobulins, Intravenouss; Pulmonary Disease, Chronic Obstructive; Pulmonary Edema; Pulmonary Embolism Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32013000179 Date abstract record published 20/03/2013 |